Microparticles of poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery

被引:112
作者
Cleek, RL
Ting, KC
Eskin, SG
Mikos, AG
机构
[1] RICE UNIV,DEPT CHEM ENGN,COX LAB BIOMED ENGN,HOUSTON,TX 77251
[2] RICE UNIV,INST BIOSCI & BIOENGN,HOUSTON,TX 77251
[3] TEXAS BIOTECHNOL CORP,DEPT CELL BIOL,HOUSTON,TX 77030
关键词
poly(DL-lactic-co-glycolic acid); poly(ethylene glycol); polymer blends; biodegradable microparticles;
D O I
10.1016/S0168-3659(97)00052-7
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We fabricated microparticles of poly(or-lactic-co-glycolic acid) (PLGA) 50:50 and poly(ethylene glycol) (PEG) blends with entrapped model drug compounds to investigate the effect of blend ratio on release kinetics. Two model drugs (FITC-IgG and FITC-dextran) were entrapped using a double-emulsion-solvent-extraction technique with high efficiency. In vitro release studies showed that the initial burst effect was dependent on the PLGA/PEG blend ratio. Moreover, the release rate increased in direct relation to PEG content for up to 28 days. A linear release profile was obtained for microparticles loaded with FITC-IgG for initial PEG weight fractions up to 5 wt%, and a constant rate of 0.021, 0.068, 0.132, and 0.214 mu g FITC-IgG/day was measured per mg polymer for formulations of 0, 1, 2, 5 wt% initial PEG content, respectively. A biphasic release profile was obtained for FITC-dextran loaded microparticles with rates dependent on the PEG content. These results demonstrate the feasibility of modulating the release profile of entrapped compounds in biodegradable microparticles by adjusting the PLGA/PEG blend ratio. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:259 / 268
页数:10
相关论文
共 30 条
[1]   BIODEGRADABLE MICROSPHERES AS CONTROLLED-RELEASE TETANUS TOXOID DELIVERY SYSTEMS [J].
ALONSO, MJ ;
GUPTA, RK ;
MIN, C ;
SIBER, GR ;
LANGER, R .
VACCINE, 1994, 12 (04) :299-306
[2]  
[Anonymous], 1997, PRINCIPLES TISSUE EN
[3]   CHARACTERIZATION OF DRUG-LOADED POLY(D,L-LACTIDE) MICROSPHERES [J].
BENITA, S ;
BENOIT, JP ;
PUISIEUX, F ;
THIES, C .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (12) :1721-1724
[4]   THE EFFECT OF THE ADDITION OF LOW-MOLECULAR WEIGHT POLY(DL-LACTIDE) ON DRUG RELEASE FROM BIODEGRADABLE POLY(DL-LACTIDE) DRUG DELIVERY SYSTEMS [J].
BODMEIER, R ;
OH, KH ;
CHEN, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 51 (01) :1-8
[5]  
CLEEK RL, 1997, IN PRESS J BIOMED MA
[6]   CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[7]   POLYMERIC MICROSPHERES AS DRUG CARRIERS [J].
DAVIS, SS ;
ILLUM, L .
BIOMATERIALS, 1988, 9 (01) :111-115
[8]   SOLUTION TECHNIQUE TO INCORPORATE POLYETHYLENE OXIDE AND OTHER WATER-SOLUBLE POLYMERS INTO SURFACES OF POLYMERIC BIOMATERIALS [J].
DESAI, NP ;
HUBBELL, JA .
BIOMATERIALS, 1991, 12 (02) :144-153
[9]   BIODEGRADABLE AND BIOCOMPATIBLE POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES AS AN ADJUVANT FOR STAPHYLOCOCCAL ENTEROTOXIN-B TOXOID WHICH ENHANCES THE LEVEL OF TOXIN-NEUTRALIZING ANTIBODIES [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
TICE, TR ;
GILLEY, RM .
INFECTION AND IMMUNITY, 1991, 59 (09) :2978-2986
[10]  
FLANDROY PMJ, 1993, PHARM PARTICULATE CA, P321